Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.

Wang Z, Goto Y, Allevato MM, Wu VH, Saddawi-Konefka R, Gilardi M, Alvarado D, Yung BS, O'Farrell A, Molinolo AA, Duvvuri U, Grandis JR, Califano JA, Cohen EEW, Gutkind JS
Nat Commun. 2021 Apr 22;12(1):2383. doi: 10.1038/s41467-021-22619-w. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.